Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in PCI (REMEDY)
NCT02205775Phase 3Terminated
- Sponsor
- Università degli Studi Gabriele d'Annunzio Chieti e Pescara
- Start
- May 2010
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in coronary artery disease (CAD), sponsored by Università degli Studi Gabriele d'Annunzio Chieti e Pescara. Started May 2010; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02205775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205775.